This hypothesis is supported by the study of Mexitalia et al. (2017), who found increases in leptin levels and energy, protein, and fat intake after anti-tuberculosis drugs isoniazid, rifampicin, and pyrazinamide administration. The gene discussed is LEP; the disease is tuberculosis.